Development of a homogeneous AlphaLISA ubiquitination assay using ubiquitin binding matrices as universal components for the detection of ubiquitinated proteins

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 11, 2012, Pages 2038-2045

  Schneider, Stephen ^a   Chen, Hao ^a   Tang, Jin ^a   Emkey, Renee ^a   Andrews, Paul S ^a  

^a AMGEN INC   (United States)

Author keywords

AlphaLISA; Mdm2; TUBEs; Ubiquitin

Indexed keywords

GLUTATHIONE; PROTEIN MDM2; PROTEIN P53; STREPTAVIDIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E1; UBIQUITIN PROTEIN LIGASE E2; UBIQUITIN PROTEIN LIGASE E3; UBIQUITINATED PROTEIN; UNCLASSIFIED DRUG;

ALPHALISA ASSAY; ARTICLE; ASSAY; HIGH THROUGHPUT SCREENING; INSECT CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; UBIQUITINATION; WILD TYPE;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; POLYUBIQUITIN; RECOMBINANT PROTEINS; TANDEM REPEAT SEQUENCES; UBIQUITINATED PROTEINS; UBIQUITINATION;

EID: 84866992684     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.03.018     Document Type: Article

References (21)

1. Hicke L. Protein regulation by monoubiquitin. Nat. Rev. Mol. Cell Biol. 2001, 2:195-201.
2. Fiore P.P.D., Polo S., Hofmann K. When ubiquitin meets ubiquitin receptors: a signalling connection. Nat. Rev. Mol. Cell Biol. 2003, 4:491-497.
3. Osley M.A., Fleming A.B., Kao C.F. Histone ubiquitylation and the regulation of transcription. Results Probl. Cell Differ. 2006, 41:47-75.
4. Deshaies R.J., Joazeiro C.A. RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 2009, 78:399-434.
5. Yang Y., Ludwig R.L., Jensen J.P., Pierre S.A., Medaglia M.V., Davydov I.V., Safiran Y.J., Oberoi P., Kenten J.H., Phillips A.C., Weissman A.M., Vousden K.H. Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells. Cancer Cell 2005, 7:547-559.
6. Fang S., Jensen J.P., Ludwig R.L., Vousden K.H., Weissman A.M. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 2000, 275:8945-8951.
7. Honda R., Tanaka H., Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 1997, 420:25-27.
8. Phillips A.C., Vousden K.H. E2F-1 induced apoptosis. Apoptosis 2001, 6:173-182.
9. Berkson R.G., Hollick J.J., Westwood N.J., Woods J.A., Lane D.P., Lain S. Pilot screening programme for small molecule activators of p53. Int. J. Cancer 2005, 115:701-710.
10. Chen Z.J. Ubiquitin signalling in the NF-kappaB pathway. Nat. Cell Biol. 2005, 7:758-765.
11. Kenten J.H., Davydov I.V., Safiran Y.J., Stewart D.H., Oberoi P., Biebuyck H.A. Assays for high-throughput screening of E2 AND E3 ubiquitin ligases. Methods Enzymol. 2005, 399:682-701.
12. Davydov I.V., Woods D., Safiran Y.J., Oberoi P., Fearnhead H.O., Fang S., Jensen J.P., Weissman A.M., Kenten J.H., Vousden K.H. Assay for ubiquitin ligase activity: high-throughput screen for inhibitors of HDM2. J. Biomol. Screen. 2004, 9:695-703.
13. Hong C.A., Swearingen E., Mallari R., Gao X., Cao Z., North A., Young S.W., Huang S.G. Development of a high throughput time-resolved fluorescence resonance energy transfer assay for TRAF6 ubiquitin polymerization. Assay Drug Dev. Technol. 2003, 1:175-180.
14. Hjerpe R., Aillet F., Lopitz-Otsoa F., Lang V., England P., Rodriguez M.S. Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. EMBO Rep. 2009, 10:1250-1258.
15. Tillett D., Neilan B. Enzyme-free cloning: a rapid method to clone PCR products independent of vector restriction enzyme sites. Nucleic Acids Res. 1999, 27:26.
16. Kim H.T., Kim K.P., Lledias F., Kisselev A.F., Scaglione K.M., Skowyra D., Gygi S.P., Goldberg A.L. Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J. Biol. Chem. 2007, 282:17375-17386.
17. Lai Z., Ferry K.V., Diamond M.A., Wee K.E., Kim Y.B., Ma J., Yang T., Benfield P.A., Copeland R.A., Auger K.R. Human mdm2 mediates multiple mono-ubiquitination of p53 by a mechanism requiring enzyme isomerization. J. Biol. Chem. 2001, 276:31357-31367.
18. Hau D.D., Lewis M.J., Saltibus L.F., Pastushok L., Xiao W., Spyracopoulos L. Structure and interactions of the ubiquitin-conjugating enzyme variant human Uev1a: implications for enzymatic synthesis of polyubiquitin chains. Biochemistry 2006, 45:9866-9877.
19. Eddins M.J., Carlile C.M., Gomez K.M., Pickart C.M., Wolberger C. Mms2-Ubc13 covalently bound to ubiquitin reveals the structural basis of linkage-specific polyubiquitin chain formation. Nat. Struct. Mol. Biol. 2006, 13:915-920.
20. Eddins M.J., Varadan R., Fushman D., Pickart C.M., Wolberger C. Crystal structure and solution NMR studies of Lys48-linked tetraubiquitin at neutral pH. J. Mol. Biol. 2007, 367:204-211.
21. Marblestone J.G., Kumar K.G., Eddins M.J., Leach C.A., Sterner D.E., Mattern M.R., Nicholson B. Novel approach for characterizing ubiquitin E3 ligase function. J. Biomol. Screen. 2010, 15:1220-1228.